PLYX — Polaryx Therapeutics, Balance Sheet
0.000.00%
Last trade - 00:00- $268.91m
- $263.16m
Annual balance sheet for Polaryx Therapeutics,, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 0.002 | 4.62 |
| Prepaid Expenses | ||
| Total Current Assets | 2.31 | 5 |
| Total Assets | 2.31 | 5 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 1.04 | 0.289 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Liabilities | 1.04 | 0.289 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | 1.28 | 4.71 |
| Total Liabilities & Shareholders' Equity | 2.31 | 5 |
| Total Common Shares Outstanding |